Mechanism of Resistance to Cetuximab Therapy in Colorectal Cancer

mAbs - United States
doi 10.4161/mabs.21311
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2019English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2018English

A Small Molecule Approach to Degrade RAS With EGFR Repression Is a Potential Therapy for KRAS Mutation-Driven Colorectal Cancer Resistance to Cetuximab

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2018English

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

The Insulin/Igf System in Colorectal Cancer Development and Resistance to Therapy

Frontiers in Oncology
Cancer ResearchOncology
2015English

Dissecting Mechanisms of Resistance to Targeted Drug Combination Therapy in Human Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Evolving Role of Cetuximab in the Treatment of Colorectal Cancer

Cancer Management and Research
Oncology
2009English

Evolving Role of Cetuximab in the Treatment of Colorectal Cancer

Cancer Management and Research
Oncology
2009English

Rechallenge and Maintenance Therapy Using Cetuximab and Chemotherapy Administered to a Patient With Metastatic Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy